BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 29788296)

  • 1. Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay.
    Pollock NR; Banz A; Chen X; Williams D; Xu H; Cuddemi CA; Cui AX; Perrotta M; Alhassan E; Riou B; Lantz A; Miller MA; Kelly CP
    Clin Infect Dis; 2019 Jan; 68(1):78-86. PubMed ID: 29788296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
    Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in Stool.
    Song L; Zhao M; Duffy DC; Hansen J; Shields K; Wungjiranirun M; Chen X; Xu H; Leffler DA; Sambol SP; Gerding DN; Kelly CP; Pollock NR
    J Clin Microbiol; 2015 Oct; 53(10):3204-12. PubMed ID: 26202120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of Single-Molecule Array Assays for Detection of Clostridium difficile Toxins in Comparison to Conventional Laboratory Testing Algorithms.
    Banz A; Lantz A; Riou B; Foussadier A; Miller M; Davies K; Wilcox M
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29898996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Clinical Specificity with Ultrasensitive Detection of Clostridioides difficile Toxins: Reduction of Overdiagnosis Compared to Nucleic Acid Amplification Tests.
    Sandlund J; Estis J; Katzenbach P; Nolan N; Hinson K; Herres J; Pero T; Peterson G; Schumaker JM; Stevig C; Warren R; West T; Chow SK
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434726
    [No Abstract]   [Full Text] [Related]  

  • 6. Nucleic Acid Amplification Test Quantitation as Predictor of Toxin Presence in Clostridium difficile Infection.
    Crobach MJT; Duszenko N; Terveer EM; Verduin CM; Kuijper EJ
    J Clin Microbiol; 2018 Mar; 56(3):. PubMed ID: 29237788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasensitive Detection of Clostridioides difficile Toxins A and B by Use of Automated Single-Molecule Counting Technology.
    Sandlund J; Bartolome A; Almazan A; Tam S; Biscocho S; Abusali S; Bishop JJ; Nolan N; Estis J; Todd J; Young S; Senchyna F; Banaei N
    J Clin Microbiol; 2018 Nov; 56(11):. PubMed ID: 30158195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stool Interleukin-1β Differentiates Clostridioides difficile Infection (CDI) From Asymptomatic Carriage and Non-CDI Diarrhea.
    Villafuerte Gálvez JA; Pollock NR; Alonso CD; Chen X; Xu H; Wang L; White N; Banz A; Miller M; Daugherty K; Gonzalez-Luna AJ; Barrett C; Sprague R; Garey KW; Kelly CP
    Clin Infect Dis; 2023 Feb; 76(3):e1467-e1475. PubMed ID: 35906836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and outcome of Clostridium difficile infection by toxin enzyme immunoassay and polymerase chain reaction in an island population.
    Kumar S; Pollok R; Muscat I; Planche T
    J Gastroenterol Hepatol; 2017 Feb; 32(2):415-419. PubMed ID: 27505006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
    Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
    Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low sensitivity of fecal toxin A/B enzyme immunoassay for diagnosis of Clostridium difficile infection in immunocompromised patients.
    Erb S; Frei R; Strandén AM; Dangel M; Tschudin-Sutter S; Widmer AF
    Clin Microbiol Infect; 2015 Nov; 21(11):998.e9-998.e15. PubMed ID: 26232535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous Detection of
    Yoo IY; Song DJ; Huh HJ; Lee NY
    Ann Lab Med; 2019 Mar; 39(2):214-217. PubMed ID: 30430786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repeat stool testing to diagnose Clostridium difficile infection using enzyme immunoassay does not increase diagnostic yield.
    Deshpande A; Pasupuleti V; Patel P; Ajani G; Hall G; Hu B; Jain A; Rolston DD
    Clin Gastroenterol Hepatol; 2011 Aug; 9(8):665-669.e1. PubMed ID: 21635969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can a toxin gene NAAT be used to predict toxin EIA and the severity of
    Garvey MI; Bradley CW; Wilkinson MAC; Holden E
    Antimicrob Resist Infect Control; 2017; 6():127. PubMed ID: 29270290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Detection of Clostridium difficile Toxins in Stool by Raman Spectroscopy.
    Koya SK; Yurgelevic S; Brusatori M; Huang C; Diebel LN; Auner GW
    J Surg Res; 2019 Dec; 244():111-116. PubMed ID: 31279995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasensitive and Quantitative Toxin Measurement Correlates With Baseline Severity, Severe Outcomes, and Recurrence Among Hospitalized Patients With Clostridioides difficile Infection.
    Alonso CD; Kelly CP; Garey KW; Gonzales-Luna AJ; Williams D; Daugherty K; Cuddemi C; Villafuerte-Gálvez J; White NC; Chen X; Xu H; Sprague R; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
    Clin Infect Dis; 2022 Jul; 74(12):2142-2149. PubMed ID: 34537841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of simultaneous glutamate dehydrogenase and toxin A/B rapid immunoassay on Clostridium difficile diagnosis and treatment in hospitalized patients with antibiotic-associated diarrhea in a university hospital of Brazil.
    Cançado GGL; Silva ROS; Nader AP; Lobato FCF; Vilela EG
    J Gastroenterol Hepatol; 2018 Feb; 33(2):393-396. PubMed ID: 28730697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 2-step algorithm combining glutamate dehydrogenase and nucleic acid amplification tests for the detection of Clostridioides difficile in stool specimens.
    Liu C; Tang C; Han Y; Xu Y; Ni F; Jin K; Liu G
    Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):345-351. PubMed ID: 32944896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasensitive Detection of Clostridioides difficile Toxins in Stool by Use of Single-Molecule Counting Technology: Comparison with Detection of Free Toxin by Cell Culture Cytotoxicity Neutralization Assay.
    Hansen G; Young S; Wu AHB; Herding E; Nordberg V; Mills R; Griego-Fullbright C; Wagner A; Ong CM; Lewis S; Yoon J; Estis J; Sandlund J; Friedland E; Carroll KC
    J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Agreement Between an Ultrasensitive Clostridioides difficile Toxin Assay and a C. difficile Laboratory Algorithm Utilizing GDH-and-Toxin Enzyme Immunoassays and Cytotoxin Testing.
    Landry ML; Topal JE; Estis J; Katzenbach P; Nolan N; Sandlund J
    J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31776192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.